The management of cryptococcal meningitis in Papua New Guinea

Papua and New Guinea Medical Journal

Volumn , Issue 1, 1996, Pages 67-73

  Seaton, R Andrew ^a,b,c  

^a UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; FLUCONAZOLE; FLUCYTOSINE; HYDROCORTISONE; ITRACONAZOLE;

BLOOD; CAUSE OF DEATH; CRYPTOCOCCAL MENINGITIS; DRUG COMBINATION; DRUG EFFECT; DRUG MONITORING; HUMAN; IMMUNOCOMPETENCE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MULTICENTER STUDY; PAPUA NEW GUINEA; REVIEW;

AMPHOTERICIN B; ANTI-INFLAMMATORY AGENTS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CAUSE OF DEATH; DRUG COMBINATIONS; DRUG MONITORING; FLUCONAZOLE; FLUCYTOSINE; HUMANS; HYDROCORTISONE; IMMUNOCOMPETENCE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; ITRACONAZOLE; MENINGITIS, CRYPTOCOCCAL; MULTICENTER STUDIES; PAPUA NEW GUINEA;

EID: 0030088969     PISSN: 00311480     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984;120: 123-130.
2. Seaton RA, Naraqi S, Wembri J. Immunological aspects of cryptococcal meningitis in PNG. Abstract in Aust NZ J Med 1995; in press.
3. Taelman H, Clerinx J, Kagame A, Batungwanayo J, Nyirabareja A, Bogaerts J. Cryptococcosis, another growing burden for central Africa. Lancet 1991;338:761.
4. Lalloo D, Fisher D, Naraqi S, Laurenson I, Temu P, Sinha A, Saweri A, Mavo B. Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q J Med 1994;87:343-349.
5. Spickard A, Butler WT, Andriole V, Utz JP. The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann Intern Med 1963;58:66-83.
6. Sarosi GA, Parker JD, Doto IL, Tosh FE. Amphotericin B in cryptococcal meningitis. Ann Intern Med 1969;71:1079-1087.
7. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Ailing DW. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979;301:126-131.
8. Wolf JE, Massof SE. In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect Immun 1990;58:1296-1300.
9. Diamond RD, Bennett JE. A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med 1973;288:186-183.
10. Young RF, Gade G, Grinnell V. Surgical treatment for fungal infections in the central nervous system. J Neurosurg 1985;63:371-381.
11. Ommaya AK. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 1963;2:983-984.
12. Coker RJ, Viviani M, Gazzard BG, Du-Pont B, Pohle HD, Murphy SM, Atouguia J, Champalimaud JL, Harris JR. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993;7:829-835.
13. Bodey GP. Azole antifungal agents. Clin Infect Dis 1992;14 Suppl 1: S161-S169.
14. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson J, Hafner R, Dismukes WE and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS associated cryptococcal meningitis. N Engl J Med 1992;326:83-89.
15. Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-187.
16. Dupont B, Dromer F, Brugière O. Fluconazole treatment of cryptococcosis in HIV-negative patients. Abstract in Programme and Abstracts of the Second International Conference on Cryptococcus and Cryptococcosis, Milan, Italy, 19-23 Sep 1993:94.
17. Dismukes WE, Saag MS, van der Horst C, Cloud G, Hafner R, Graybill JR, Powderly WG and others in the Joint Study by the NIAID AIDS Clinical Trials Group and Mycoses Study Group. Induction therapy with amphotericin B alone versus flucytosine plus amphotericin B, followed by consolidation therapy with fluconazole or itraconazole for the treatment of AIDS-associated cryptococcal meningitis: preliminary observations. Abstract in Programme and Abstracts of the Second International Conference on Cryptococcus and Cryptococcosis, Milan, Italy, 19-23 Sep 1993:98.
18. Quagliarello VJ, Viscoli C, Horwitz RI. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet 1995;345:548-552.
19. Denning DW. Itraconazole therapy of cryptococcosis. Abstract in Programme and Abstracts of the Second International Conference on Cryptococcus and Cryptococcosis, Milan, Italy, 19-23 Sep 1993:102.
20. Department of Neurology and Traditional Chinese Medicine and Pharmacology of the First Affiliated Hospital and Department of Microbiology, Hunan Medical College, Changsha. Garlic in cryptococcal meningitis. Chin Med J 1980;93:123-126.
21. Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine 1993;72:207-224.
22. Tan CT. Intracranial hypertension causing visual failure in Cryptococcus meningitis. J Neurol Neurosurg Psychiatry 1988;51:944-946.
23. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91:267-272.